Osten, Germany

Michael Althaus

This inventor holds 5 USPTO granted patents and 6 published patent applications and 4 EPO patents. Top assignees: Merz Pharma Gmbh & Co Kgaa, Merz Pharma Gmbh & Co. Kgaa. Active years: 2014-2025.

USPTO Granted Patents = 5 

% Patents Active = 60.0

 

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Schoeneck, DE (2014)
  • Schoeueck, DE (2016)
  • Osten, DE (2020 - 2022)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Michael Althaus: Innovator in Botulinum Neurotoxin Applications

Introduction

Michael Althaus is a notable inventor based in Osten, Germany. He has made significant contributions to the field of medical treatments, particularly in the use of botulinum neurotoxins. With a total of 5 patents to his name, Althaus continues to push the boundaries of innovation in healthcare.

Latest Patents

One of Althaus's latest patents focuses on the use of botulinum neurotoxin in the treatment of sialorrhea. This invention relates to improved applications of botulinum neurotoxins for managing conditions associated with excessive saliva production. Specifically, the patent details the administration of these neurotoxins into the parotid and submandibular glands at a dose ratio between 1.45 to 1 and 1.7 to 1. This innovative approach aims to enhance the effectiveness of treatment for patients suffering from sialorrhea.

Career Highlights

Michael Althaus is currently associated with Merz Pharma GmbH & Co KGaA, where he applies his expertise in neurotoxin research. His work has been instrumental in developing new therapeutic strategies that improve patient outcomes. Althaus's dedication to innovation in medical treatments has established him as a respected figure in his field.

Collaborations

Throughout his career, Althaus has collaborated with talented professionals, including Janos Csikos and Irena Pulte. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.

Conclusion

Michael Althaus is a pioneering inventor whose work in botulinum neurotoxins has the potential to transform treatment options for patients with sialorrhea. His contributions to the field highlight the importance of innovation in medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…